Congress Materials -European Association of Urology (EAU 2026)
2026 European Association of Urology | Mar 13-18 | London, UK
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Final Analysis of the Phase 1 First‑in‑Human Study of Erda-iDRS, an Erdafitinib Intravesical Drug-Releasing System, in Patients With Non–Muscle‑Invasive Bladder Cancer Harboring Select FGFR Alterations
Antoni Vilaseca, Roger Li, Joshua Meeks, Ja Hyeon Ku, Siamak Daneshmand, Gautam Jayram, Taek Won Kang, Carles Raventos, Neal Shore, Daniel Zainfeld, Severine Banek, Ji Youl Lee, Ho Kyung Seo, Florian Roghmann, Justin Matulay, Neil Beeharry, Carrye R. Cost, Anna Kalota, Josh Lauring, Michelle R. Peterson, Nicole L. Stone, David Weingeist, Wei Zhu, Félix Guerrero-Ramos
This document will be available on Mar 12th 2026
Longitudinal Assessment of Urine Tumor DNA in High‑Risk Non‑Muscle Invasive Bladder Cancer Patients
James W.F. Catto, Siamak Daneshmand, Renata Zaucha, Ben Tran, Viraj Master, Yair Lotan, Geraldine Pignot, Andrea Tubaro, Nobuaki Shimizu, Nikhil Vasdev, Eugene K. Lee, Giuseppe Procopio, Fernando Galanternik, Daniel S. Fischer, Trevor G. Levin, Jiarui Zhang, Shibu Thomas, Nicole Stone, Spyros Triantos, Neil Beeharry
This document will be available on March 14 2026
Periprocedural Prophylactic Antibiotic Use With Gemcitabine Intravesical System (Gem‑iDRS) Monotherapy: Analysis of Data From SunRISe‑1
Daniel Zainfeld, Brian Mazzarella, Takashi Kawahara, Christopher M. Pieczonka, Evanguelos Xylinas, Diederik Somford, Hussein Sweiti, Shalaka Hampras, Jason Martin, Abhijit Shukla, Katharine Stromberg, Karel Decaestecker, Sabrina Falkowski, Justin T. Matulay, David S. Morris
This document will be available on March 15 2026
Subsequent Treatment Patterns and Outcomes Among Patients With Muscle Invasive Bladder Cancer (MIBC) Receiving Neoadjuvant Treatments: A Real‑World Data Analysis
Andrea Necchi, Sam S. Chang, Lydia Almeida, Eleanor Caplan, Steven Pisano, Ariel B. Bourla, Ran Sun, Joel Greshock, Wendy Crist, Won Kim, Sumeet Bhanvadia
This document will be available on March 15 2026
Symptoms, Health‑Related Quality of Life, and Burden Among Patients With High‑Risk Non‑Muscle Invasive Bladder Cancer and Caregivers
Jonathan Aning, Lucy Andersen, Ruhee Jain, Sarah Cote, Siobhan Mulhern-Haughey, Kristi Bertzos, Mia Unsworth, Laure Manuel, Elliott Brown, Jack Cookson, Kazutoshi Fujita, Zhisong He
This document will be available on March 15 2026
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.